PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Aug-2022 LYNPARZA® (olaparib) Approved in the EU as Adjuvant Treatment for Patients With Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer Businesswire
04-Aug-2022 InfuSystem Reports Second Quarter 2022 Financial Results Businesswire
04-Aug-2022 Stevanato Group Reports Second Quarter 2022 Financial Results Businesswire
04-Aug-2022 Global Air Cargo Container Market to Grow by $203.69 Million by 2026 - ResearchAndMarkets.com Businesswire
04-Aug-2022 Biodesix Announces Second Quarter 2022 Results and Highlights Businesswire
04-Aug-2022 North America Insulated Shipping Containers Market Report 2022: Growth in the Pharmaceutical and Healthcare Sector to Boost Demand - ResearchAndMarkets.com Businesswire
04-Aug-2022 Sheet Metal Fabrication Services Global Market Report 2022: Demand for Fabricated Metal Parts from Varied End-Use Sectors Sets the Growth Trend in Sheet Metal Fabrication Services Market - ResearchAndMarkets.com Businesswire
04-Aug-2022 Mid-Size Pharmaceutical Market Report 2022: Increasing Prevalence of Chronic Disorders along with Increasing Product Approval and Launches Driving Growth - ResearchAndMarkets.com Businesswire
04-Aug-2022 Contact Lenses Global Market Report 2022: Direct-to Consumer, Subscription Services & Online Sales Gain Traction and Drive Growth - ResearchAndMarkets.com Businesswire
04-Aug-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
04-Aug-2022 European Commission Approves IMBRUVICA® (ibrutinib) in a Fixed-Duration Combination Regimen for Adult Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL) Businesswire
04-Aug-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Mercury Systems, Inc. (MRCY) on Behalf of Investors Businesswire
03-Aug-2022 Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Businesswire
03-Aug-2022 Change Healthcare Inc. Reports First Quarter Fiscal 2023 Financial Results Businesswire
03-Aug-2022 Bio-Rad Acquires Curiosity Diagnostics Businesswire
03-Aug-2022 Glaukos Announces FDA 510(k) Clearance of iStent infinite® Businesswire
03-Aug-2022 Glaukos Corporation Announces Second Quarter 2022 Financial Results Businesswire
03-Aug-2022 Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update Businesswire
03-Aug-2022 KORU Medical Systems Announces 2022 Second Quarter Financial Results Businesswire
03-Aug-2022 Xencor Reports Second Quarter 2022 Financial Results Businesswire